Why publish only part of your findings?

Digital Chosunilbo: Korea: PPA has long been known as a dangerous ingredient in cold medicines. Products containing PPA have been banned in the U.S. for a number of years.

This story says the Korean FDA at first only published a portion of its earlier report–and pretty much led people to believe that the connection to hemorrhagic stroke (ruptured blood vessel in the brain) wasn’t clear. For some reason, they’re now publishing the whole report–which states that the connection is very clear. In fact, the latest research indicates PPA is also a factor in causing ischemic stroke, the much more common type (blockage of a blood vessel in the brain).

Strange and seemingly unethical behavior. Did they just not want to give up making money from the distribution of those drugs?